medxtmc
MEDx Translational Medicine Co., Ltd (MEDx TMC) is a Suzhou, China based precision medicine company founded in 2013, formerly QIAGEN (Suzhou) Translational Medicine. It is a leading provider of companion diagnostics (CDx) and total precision-medicine solutions, offering pharma services (biomarker discovery, target validation, patient stratification, IVD/CDx R&D and commercialization), clinical testing panels for solid tumors, blood cancers and infectious diseases, and diagnostic products built on IHC, PCR and NGS platforms. MEDx has collaborated with 400+ pharmaceutical and technology partners and holds ISO 13485, ISO 17025, CAP and CNAS accreditations. It is a portfolio company of Qiming Venture Partners. MEDx TMC publishes no public developer API, developer portal, or SDKs; this profile captures company identity for the API Evangelist network.
medxtmc is profiled on the APIs.io network. Tagged areas include Company, Precision Medicine, Companion Diagnostics, Molecular Diagnostics, and Biomarkers.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 2
The organization behind the API